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1. Introduction 
It has been shown that several fragments of the 
polypeptide /3-lipotropin (/3-LPH) have affinity for 
the opioid receptor [l-4] . In addition to the PLPH- 
(61-65)-pentapeptide termed methionine-enkephalin 
(Met5-enkephalin) another pentapeptide leucine- 
enkephalin (Leu5-enkephalin) has been isolated [5,6] . 
The enkephalins and /3-LPH, fragments, as well as 
some analogues of the former, display properties 
similar to those of morphine in receptor-binding 
studies [7] , in their action on electrically stimulated 
guinea pig ileum [5] and in the central nervous system, 
where they cause analgesia [8]. Like morphine these 
peptides can be specifically antagonized by naloxone 
in these assay systems. It is also known that the eleva- 
tion by prostaglandin E, (PGE1) of the intracellular 
level of adenosine 3’:5’-cyclic monophosphate (cyclic 
AMP) [9] in neuroblastoma X glioma hybrid cells 
108CC15 is inhibited by narcotics [ 10,l l] and enke- 
phalins [ 12,131. These cells display many properties 
characteristic of neurones [ 14,151. They constitute 
a useful model for studying the effects of opioids on 
the adenylate cyclase system in relation to receptor- 
binding. Here we report on the levels of cyclic AMP 
in neuroblastoma X glioma hybrid cells simultaneously 
exposed to PGEl and various /?-lipotropin fragments 
or their analogues. We also compare the changes of 
cyclic AMP levels with the characteristics of the bind- 
ing of the same peptides to the opioid receptor in 
rat brain synaptic membranes. 
2. Materials and methods 
The synthesis and the analytical data of Met’- 
enkephalin, Leu’-enkephalin, /3-LPH-(61-69)-nona- 
peptide, /3-LPH-(61-75)pentadecapeptide and the 
analogues Phe’,Met’-, Des-Met’- and Ala2,Leu5-enke- 
phalin have been reported [7,12,16]. The homo- 
geneous crystalline compounds 
H-Tyr-Gly-Gly-OH monohydrate 
(m.p. 174-176’C; [QI]:$ + 65.8”C and [CZ] 2 + 
54.4’C (c = 2.0,20% acetic acid)). 
H-Gly-Phe-Leu-OH monohydrate (m-p. 224- 
225’C; [(Y]$& - 15.7”C and [(YIP - 13.9”~ (c= 0.2, 
80% 2-methoxyethanol)). 
Homogeneous H-Arg-Tyr-Gly-Gly-Phe-Leu-OH 
monoacetate (m.p. 175-178’C; [Q]::~ + 24°C 
and [alho t 19.5’C (c = 1.0,95% acetic acid)). 
Amino acid ratios in acid hydrolysate: Arg 1 .Ol (l), 
Tyr 0.97 (l), Gly 2.03 (2), Phe 0.99 (l), Leu 1 .01(l) 
and AI-M digest: Arg 1.04 (l), Tyr 1 .OO (I), Gly 
2.00 (2), Phe 1.02 (l), Leu 0.98 (1)). 
Desamino-Met’-enkephalin (m.p. 161-163°C; 
kd::, -4.6”C and [c~]g and -4.2’C (c = 1 .O, 
95% acetic acid)) and 
Me’-enkephalin hemihydrate (m.p. 200-202°C; 
[al 2046 t 39.8”C and [a] g + 32.5’C (c = 0.9, 
95% acetic acid) were synthesized by L.M. and 
E.W. 
Amino acid ratios in acid hydrolysate: Tyr 0.98 
(l), Gly 2.00 (2), Phe 0.97 (I), Me 0.97 (1)). 
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PGEr was a gift from Dr J. Pike, Upjohn Co., 
Kalamazoo, Michigan. Morphine . HCl, was purchased 
from Boehringer, Ingelheim, Germany, levorphanol 
tartrate and naloxone . HCl were gifts from Hoffmann- 
La Roche, Grenzach, Germany and Endo Labora- 
tories, Garden City, NY, USA, respectively. 
Four days before the experimental incubation 
2.4 X 10’ viable (exclusion of nigrosin) neuroblas- 
toma X glioma hybrid cells 108CClS were seeded in 
plastic Petri dishes (85 mm in diameter) containing 
20 ml growth medium [171. After the experimental 
incubation (10 min, 37°C) in the presence of PGEr 
and the peptides, the intracellular concentration of 
cyclic AMP was determined [ 171. The opiate 
receptor-binding assay has been described in detail 
elsewhere [ 181. 
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Fig.1. Inhibition by various concentrations of opioid peptides 
of the increase in the level of cyclic AMP evoked by 0.3 PM 
PGE, . Curve (I) Led enkephalm, curve (II) B-LPH-(6 l-69), 
curve (III) p-LPH-(61-75). 3.0 X 16’ viable cells/plate, 
viability 95%, passage number 14. Mean values + SD from 
three parallel incubations. 
3. Results 
The enkephalins, the &LPH-(61-69)nonapeptide 
and the /3-LPH-(61-7S)pentadecapeptide strongly 
inhibited the increase in the level of cyclic AMP 
evoked by PGEr (fig.1). The parallel concentration- 
inhibition curves allow quantitative comparison of 
potency. Met’-Enkephalin (curve not shown) and 
Leu’-enkephalin were equipotent (I&: 1-3 nM). 
/I-LPH-(61-69) (I&,: 10 nM) and /I-LPH-(61-75) 
(I&,: 60 nM) were less potent. Table 1 shows that 
10 nM naloxone prevented the inhibitory effect of the 
peptides. Let?-Enkephalin [191 and /3-LPH-(6 l-69) 
and fl-LPK(61-75) lower the level of cyclic AMP 
even in the absence of PGEr . Structural analogues 
of the enkephalins were also tested. The results are 
compared with those of morphine and levorphanol 
(table 2). With the exception of Nle’-enkephalin all 
analogues were less potent than the enkephalins in
attenuating the effect of PGEr. However, most of 
them were more potent than levorphanol and morphine. 
Most interestingly, acylation by an arginyl residue of 
the amino group of Let?-enkephalin reduced the 
potency only by one order of magnitude. Strikingly 
in the rat brain receptor affinity test, the peptides 
were generally less potent than the opiates. This is 
obvious if one compares the ratio, ICse/KD for the 
Table 1 
NaIoxone blocks the inhibitory effect of opioid peptides on 
the increase in the level of cyclic AMP evoked by PGE, 
Substance added cyclic AMP 
(fiM) (pmol/mg protein) 
None 38+ 6 
Naloxone (10) 60+ 11 
PGE, (0.3) 1850 * 470 
p-LPH-(6 l-69) (0.1) 21* 7 
@-LPH-(61-75) (1) 29* 2 
PGE, + naloxone 1920* 80 
@LPH-(6 l-69) + naloxone 41* 3 
p-LPH-(61-75) + naloxone 38+ 6 
PGE, + Leus -enkephaIin 241* 8 
PGE, + &LPH-(61-69) 293 f 27 
PGE, + fl-LPH-(61-75) 288 f 18 
PGE, + p-LPH-(61-69) + naloxone 1890 * 270 
PGE, + @LPH-(6 l-75) + naloxone 1730 f 100 
The data f SD are mean values obtained from 3 parallel plate. 
2.4 X lo6 Viable cells/plate, viability 95%, passage No. 16 
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Table 2 
Comparison of the potency of various opioids in the neuroblastoma X glioma hybrid cell 
system and in the rat brain synaptic membrane system 
Substance Inhibition of Binding to Ratio 
PGE,-effect on receptors 
cyclic AMP level in rat brain 
in hybrid cells membranes 
IC,, (nM) KD (nM) IC&D 
Levorphanol 300 3 100 
Morphine 500 17 300 
Mets-Enkephalin (H-Tyr-Gly-Gly-Phe-Met-OH) 3 17 0.18 
Leus-Enkephalin 3 40 0.08 
H-Tyr-Ala-Gly-Phe-Leu-OH 50 1200 0.04 
H-Arg-Tyr-Gly-Gly-Phe-Leu-OH 30 100 0.3 
H-Tyr-Gly-Gly-Phe-Nle-OH 1 30 0.03 
H-Phe-Gly-Gly-Phe-Met-OH 2000 100 000 0.02 
H-Tyr-Gly-Gly-Phe-OH 10 000 50 000 0.2 
p-LPH-(61-69) 10 13 0.77 
PLPH-(61-75) 60 100 0.6 
In the hybrid cell system the inhibitory action on the PGE,-evoked stimulation of cyclic AMP accumulation was 
studied. In the membrane system the affinity to opioid receptors was measured. Each IC,, value was obtained 
from dose-response curves analogous to those of fig.1. 
opiates and the peptides (table 2). A number of 
peptides were ineffective, i.e., their ICse-values were 
higher than 10 000 nM. These were: H-Tyr-Gly- 
Gly-OH (fl-LPH-(61-63)). H-Gly-Phe-Leu-OH 
alone and in combination with /I-LPH-(61-63) and 
desamino-Met’-enkephalin. 
4. Discussion 
In the hybrid cells, not only the action of the 
enkephalins [ 1 l] but also that of the longer fl-LPH- 
fragments LPH-(61-69) and LPH-(61-75) is blocked 
by the opiate-antagonist naloxone. This indicates that 
the peptides are acting by binding to opioid receptors. 
Isosteric substitution by norleucine in position 5 of 
enkephalin rendered a peptide somewhat more active 
than the enkephalins. Omission from the enkephalins 
of the C-terminal or of one [7,20] or two N-terminal 
amino acids or of just the amino group from tyrosine 
yields oligopeptides devoid of, or almost lacking 
activity in both assay systems used here. An enkephalin 
without the phenolic hydroxyl group retains some 
30 
activity. Interestingly, elongation of the chain at the 
carboxyl-end by up to 10 amino acids or replacement 
of Gly in position 2 by LAla reduced activity by 
only one order of magnitude. The tyramine amino 
group’ of opiates has been considered essential for 
biological activity. The fact that the tyrosine of the 
enkephalins is located at the amino-end, rather than 
in the internal sequence, appeared to support this 
notion [21]. Surprisingly, acylation by an arginyl 
residue of the tyrosine amino group in Leu’-enkephalin 
caused but a moderate loss of potency. This demon- 
strates that maintenance of an amino group or a posi- 
tive charge in this position is not under all circum- 
stances required for activity. Results from opiate- 
binding studies led other authors to the same conclu- 
sion [22] . This peptide or its Me@-analogue could 
arise from a hypothetical variant of p-LPH or from 
/3-LPH, respectively, by tryptic cleavage of the Lyss9- 
Arg6’ peptide bond. This possibility and the surprising 
potency of the peptide may suggest its natural 
occurrence and function. In conclusion, considerable 
changes in the structure, especially chain-elongation 
at the carboxyl-end, are tolerated by the enkephalins 
without extensive loss of biological activity. 
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For the peptides, the ranking order of potency is 
similar in the two systems used here and in test 
systems which analyse analgesic activity [8]. Thus, 
there is good evidence that the two functional 
responses, the inhibition of the increase in the level 
of cyclic AMP and the analgesic action, are related 
and are elicited via interactions of the peptides with 
the receptors that can be detected with a binding 
assay. 
However, if the peptides are compared with the 
opiates, clear discrepancies of potency are found 
between the systems. In the hybrid cell system the 
opiates are much less potent than the peptides in 
inhibiting the increase in the concentration of cyclic 
AMP caused by PGEi. In the receptor-binding studies 
(rat brain synaptic membranes) the situation is the 
reverse (table 2). It is very unlikely that this large 
difference is simply due to peptide metabolism during 
the receptor-binding assay. When tracer amounts of 
enkephalin were incubated with the membranes 
carrying the receptors, more than 25% remained as 
intact enkephalin at the end of the incubation [23]. 
As a possible alternative is considered that in the two 
systems, hybrid cells and rat brain membranes, respec- 
tively, the peptides and the opiates interact with 
different receptors. 
In case opiates and peptides would act on the same 
receptor they would be expected to be antagonized 
by the same antagonist and at a given concentration of 
an antagonist, a certain agonistic effect should be 
reduced to the same extent [24]. Indeed, this is 
observed in the hybrid cell system with naloxone as 
the antagonist and either Leu’ -enkephalin [ 121 or 
morphine as agonists [ 11,25] . Using the dose-ratio 
method, KIee and Nirenberg made a similar observa- 
tion and calculated the K, (equilibrium binding con- 
stant) for naloxone to be 30 nM and 20 nM against 
Met’-enkephalin and morphine, respectively. This 
suggests that naloxone competes with morphine and 
the enkephalins for the same binding sites. However, 
an analogous analysis of the synaptic plasma mem- 
brane receptors gives different results. Naloxone was 
allowed to compete with labelled enkephalins or 
dihydromorphine under strictly identical conditions 
following the procedure of Terenius and Wahlstrijm 
[26]. The K, values of 0.7 nM, 10 nM and 10 nM for 
naloxone against dihydromorphine, Let?-enkephalin 
and Met’-enkephalin, respectively, were observed. 
Further support for a heterogenous receptor-popula- 
tion in synaptic plasma membranes has been obtained 
using several competitors against labelled dihydro- 
morphine or labelled Let?-enkephalin. Thus, in addi- 
tion to classical ‘morphine sites’, there is evidence for 
additional ‘enkephalin’ sites [23] . 
The difference between the hybrid cell and synaptic 
plasma membrane system are probably real although 
differences in experimental conditions may play a 
role. Our tentative hypothesis is that the hybrid cell 
membrane has only ‘enkephalin sites’ with high 
affinity for the peptides but low affinity for opiates. 
It would be of interest to carry out receptor-binding 
studies on neuroblastoma X glioma hybrid cells to 
evaluate this hypothesis. 
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1. Introduction 
A sequential step-wise increase in activities of a 
number of mitochondrial enzymes [l-4] , as well 
as in concentrations of cytochromes [5] and of 
cardiolipin [5,6] were found to take place during 
the aerobic synchronous growth of yeast-cells. This 
points to a discontinuous and time-ordered formation, 
or at least complementation f mitochondria in the 
cell-cycle of this organism. 
Similar step-wise changes in activities of mito- 
chondrial enzymes were also observed in anaerobi- 
cally-grown yeast during a subsequent synchronous 
growth under aerobic conditions [2]. In this case, 
not only the formation of new mitochondria but 
also a transformation of preformed anaerobic mito- 
chondria (promitochondria) into aerobic mitochon- 
dria [7- 111 took place. The question whether the 
latter process did also proceed in a step-wise manner 
has remained unresolved. 
The present paper shows that the activities of 
cytochrome c:02 oxidase (EC1.9.3.1.), NADH: 
cytochrome c reductase (ECl.6.2.1), succinate:PMS 
reductase (ECI.3.99.1) and Lmalate dehydrogenase 
(EC1 .l .1.37) increase in a sequential step-wise manner 
when synchronous anaerobically-grown cells undergo 
respiratory adaptation under non-growing conditions. 
This strongly suggests hat the transformation of
promitochondria nto aerobic mitochondria in the 
yeast cells is a synchronous time-ordered process. 
North-Holland Publishing Company - Amsterdam 
2. Materials and methods 
Cells of Saccharomyces cerevisiae DT XII were 
grown under strictly anaerobic onditions for 17 h 
at 30°C in a semisynthetic medium [12] with 5% 
glucose as carbon source, supplemented with 0.25% 
Tween-80,0.005% ergosterol and 0.4% ethanol. 
Synchronous cells were prepared from the _ 
asynchronous culture by isopycnic gradient centri- 
fugation procedure [13 ] as described previously 
DA. 
Synchronous non-budding cells representing a 
population in a middle of the Gi-phase of the 
cell-cycle were suspended in 50 mM potassium 
phosphate, pH 5.0, containing 0.25% glucose to a 
concentration 10’ cells/ml and incubated under 
strong aeration at 30°C. Samples were taken in 
15 min intervals directly into ice-cold mixture of 
cycloheximide and cbloramphenicol (final concentra- 
tions 50 pg/ml and 4 m&r& respectively) to prevent 
protein synthesis. Washed cells were disintegrated 
with ballotini glass beads [6] and the homogenates 
analysed for enzyme activities. Spectrophotometric 
assays were performed to measure the activities of 
NADH: cytochrome c reductase [ 161, cytochrome 
oxidase [171, succinate:PMS reductase [la] and 
malate dehydrogenase using of Boehringer MDH W 
Test. 
33 
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3. Results and discussion 
During four hours of respiratory adaptation of the 
anaerobically-grown synchronous cells in the 
buffered glucose solution the cells underwent 
practically no growth and no multiplication; total 
protein increased by 18-23% and the cell number by 
5-10 (f&l). At the same time, however, the activity 
of NADH:cytochrome c reductase rose as many as 
11 times, that of cytochrome oxidase about 10.5 
times, of malate dehydrogenase 4.5 times and of 
succinate:PMS reductase 5times. As shown in fig.2 
the increase of cytochrome oxidase and NADH: 
cytochrome c reductase activities were step-wise at 
a definite time interval. A minor antimycin A 
insensitive part of the latter increased at a different 
time interval than the antimycin A sensitive part 
(fig.3) which represented about 80% of the total 
NADH:cytochrome c reductase activity. 
Malate dehydrogenase activity increased in two 
steps as it did during aerobic synchronous growth of 
anaerobically-grown yeast [2], the first minor com- 
ponent having probably corresponded the cytosolic 
enzyme. 
As can be seen from tig.2, the rise in succinate 
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“I’ Fig.2. Time-course of the increase in NADH:cytochrome c 
reductase (NCR), cytochrome oxidase (CO), malate 
dehydrogenase (MDH) and succinate dehydrogenase (SDH) 
activities during the respiratory adaptation of the synchro- 
nous anaerobically-grown yeast-cells under non-growing 
conditions. 
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F&l. Time-course of the cell-number during the respiratory 
adaptation of the synchronous anaerobically-grown 
tiiwcharomyces cerevisiue under non-growing conditions 
(NG) and separately made growth curve of the same cell- 
population in the growth medium (G) for the control of 
cell-synchronicity. 
dehydrogenase activity exhibited an oscillatory 
pattern which was not observed uring the aerobic 
synchronous-growth of both aerobically- and anae- 
robically-grown Saccharomyces cerevisiae [ 1,2] . 
This may be an expression of a feed-back control 
of the synthesis of this dehydrogenase. Oscillation 
in enzyme activity in the cell-cycle was observed 
with other organisms and considered as a characteris- 
tic of unstable nzymes [141. 
The relative time sequence of increase in activity 
of all the enzymes tudied in these experiments with 
non-growing cells has been found the same as in 
34 
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Fig.3. Time-course of the increase in total NAJHkcytochrome c reductase (NCR), antimycin sensitive (AS) and antimycin 
insensitive (AI) parts of this enzyme activity during the respiratory adaptation of the synchronous anaerobically-grown 
yeast-cells under non-growing conditions. 
experiments with aerobic synchronously growing 
cells [ 1,2]. 
It might be inferred that the synthesis of the 
respiratory-chain components in a cell is a sequen- 
tial time-ordered process independently of whether 
the components are then being inserted into preform- 
ed mitochondria during respiratory adaptation of 
anaerobically-grown cells or into newly arising mito- 
chondria during cell-growth and multiplication. This 
would be in accord with the hypothesis of sequen- 
tional transcription of genes in the cell-cycle of 
yeast [ 151. It is quite clear, however, that such an 
interpretation would be too simple to account for a 
highly complex and coordinate assembly of mito- 
chondria in which transcription of both nuclear and 
mitochondrial genes, as well as translational and a 
‘pool-size’ controls have been implicated by many 
studies. Synchronous and synchronized yeast-cells 
offer excellent opportunities for further exploration 
of this problem which is tightly connected with the 
‘04 clock’ running even at the stopped cell-growth 
and division. 
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